Ruth Oliver1,2, Linda Ly1,2, Chenyu Wang1,2, Heidi Beadnall2, Ilaria Boscolo Galazzo3,4, Michael Chappell5,6, Xavier Golay7, Enrico De Vita7, David Thomas7, and Michael Barnett1,2
1Sydney Neuroimaging Analysis Centre, Sydney, Australia, 2University of Sydney, Sydney, Australia, 3Institute of Nuclear Medicine, University College London, London, United Kingdom, 4Department of Neuroradiology, University Hospital Verona, Verona, Italy, 5Institute of Biomedical Engineering, University of Oxford, Oxford, United Kingdom, 6FMRIB Centre, University of Oxford, Oxford, United Kingdom, 7Institute of Neurology, University College London, London, United Kingdom
Synopsis
ASL is a low resolution imaging modality
that suffers from the partial volume effect, leading to an underestimation of GM
perfusion. This effect has two principle causes; blurring from the point spread
function in the slice direction, and inadequate resolution due to the need for
large voxels to achieve sufficient SNR. Both may act as confounders for measurement
of GM CBF abnormalities. Decreased GM perfusion could reflect neuronal loss or
metabolic dysfunction; PV correction allows a decoupling of structure and
function. We present the first application of a complete PV correction solution
for ASL to a cohort of MS patients.Purpose
To apply partial volume correction to ASL
data from patients with MS to improve the accuracy of grey matter (GM) CBF estimates
and facilitate the measurement of perfusion changes as a biomarker of treatment
response.
Introduction
ASL is a low resolution imaging modality known
to suffer from the partial volume (PV) effect, leading to an
underestimation of GM perfusion. The PV effect has two principle
causes: blurring from the point spread function (PSF) in the slice direction,
due to the long echo train employed, and inadequate sampling resolution due to
the need for large voxels to achieve sufficient SNR
1. Both these
effects may act as confounders for the measurement of GM CBF abnormalities. A
decrease in GM perfusion could reflect neuronal loss or metabolic dysfunction;
PV correction techniques allow decoupling of structure and function. It is
hypothesized that reduced GM perfusion after PV correction may serve as a
biomarker of reversible neuronal dysfunction prior to substantive tissue loss
2.
In this work, we present the first application of a complete PV correction
solution for ASL to a cohort of MS patients.
Methods
Six RRMS patients (5F, 1M aged 24-56Y,
mean=43.5Y, EDSS scores ranged from 1.0 to 3.5; mean=2.3) were imaged on a GE
MR750 3T scanner with 8 channel head coil. Acquisitions included: T2 FLAIR (TE/TR=162/8000ms, TI=2181ms, matrix=512x512x480, resolution=0.47x0.47x0.6mm
3) for lesion characterization and T1-weighted
anatomical IR-SPGR for tissue concentration (TE/TR=2.8/7.1ms, TI=450ms, FA=12°,
matrix 512x512x248, resolution=0.47x0.47x0.7mm
3). The ASL sequence
was pCASL labeling with 8-arm 3D stack-of-spirals read-out (inflow time=1525ms, bolus length=1525ms, matrix 128x128x32, resolution=1.88x1.88x5mm
3).
MS lesions were manually segmented on the FLAIR image using Jim
3
software to create lesion masks. FSL's
4 lesion infilling was used to
in-paint the lesions on the anatomical image, prior to segmentation into GM, WM, CSF components using FSL FAST. The segmentations were downsampled to
perfusion space using FSL’s flirt and applywarp functions to ensure the PV maps
within each ASL voxel represented the average PV estimate across the high-resolution region
5. The 1D PSF in the slice direction was estimated
using the Extended Phase Graph algorithm for the difference and proton density
images
6. These images were both deblurred using the calculated PSF with a Richardson-Lucy deconvolution
algorithm, in order to restore signal to the voxel of origin. The images were PV
corrected using a 3 x 3 x 3 kernel in a linear regression algorithm before
combining to produce separate maps of GM and WM CBF
7. Regions of
interest (ROI) were created from a Freesurfer parcellation
8 which
was transformed to ASL space in the same manner as the PV estimates and the
mean GM or WM CBF was calculated for each of these.
Results
The 1D PSF in the slice direction was
estimated to be 1.6 and 1.3 voxels at full width half maximum for the ASL difference and proton density images
respectively. ASL and proton density images for patient 002NN before and after
deblurring are shown in fig. 1,2. Middle slice CBF and PV-corrected GM and WM CBF are
shown in fig. 3. Fig. 4 shows the mean GM and WM CBF with and without
deblurring for all 6 subjects, which shows a broad trend of increased GM and
reduced WM CBF. There was a consistent increase in GM CBF with the inclusion of
deblurring compared to without, ranging from 5-12%, mean 8%. In 4 out of 6
subjects, the WM CBF decreased by -2 to -11%, mean -5%. For subject 004SS, there
was no change, and a 1% increase for 006JF. Fig. 5 shows the mean regional CBF and GM CBF post-correction, as well as the WM CBF.
Discussion
We observed significant through-plane blurring
in 3D ASL images, even in highly-segmented acquisitions. The combination of deblurring and PV-correction produces an increase in mean
GM CBF and a decrease in WM CBF over and above that produced by either correction alone. GM CBF values are modified to a greater extent than
WM CBF, due to the cortex being significantly thinner than the width of the
PSFs and GM voxels therefore suffering more signal attenuation. WM CBF values for these MS patients were higher than usually observed in healthy cohorts. Elevated WM CBF preceding lesion development has previously been observed in MS patients, which suggests that CBF may be sensitive to inflammation and serve as a early stage biomarker of lesion formation9,10.
Conclusion
More accurate estimations of GM and WM CBF
can be obtained by applying PV-correction solutions that correct for both PSF blurring and tissue heterogeneity. This will be particularly important for SPMS patients, who
exhibit tissue atrophy over the disease course.
Acknowledgements
Thanks to Fernando Zelaya for his assistance with the GE ASL sequence.
We acknowledge partial funding from Biogen for this study.
References
1. Asllani, I. MRM 2008 2. Debernard, L.
JNNP 2014 3. www.xinapse.com 4. http://fsl.fmrib.ox.ac.uk/fsl 5.
Chappell, MA. MRM 2011 6. Hennig, J. J Mag Res 1988 7 Oliver, RA. PhD thesis
2015. 8. http://freesurfer.net 9. Paling, D. J Cere Blood Flow & Metab. 2013 1-9 10. Wuerfel, J. Brain 2004 127:111-119